![Karin Kleinhans](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Karin Kleinhans
Private Equity Investor chez
Merck Research Ventures
Profil
Dr. Karin Kleinhans is an Advisor at Berlin Institute of Health, a Partner at Merck Research Ventures and a Partner at EQT Life Sciences Group BV.
Dr. Kleinhans was previously employed as a Partner by EQT Partners GmbH, a Partner by LSP Services Deutschland GmbH, and a Member by EQT Life Sciences Group BV.
She also served on the board at Arcum Therapeutics, Inc., T-Knife GmbH and Cardior Pharmaceuticals GmbH.
She received her undergraduate degree from Universität Ulm, a graduate degree from Universität Ulm and a doctorate degree from Universität Ulm.
Postes actifs de Karin Kleinhans
| Sociétés | Poste | Début |
|---|---|---|
Merck Research Ventures
 Merck Research Ventures Investment ManagersFinance Merck Research invests in companies located globally. The firm targets companies operating in the therapeutics sector. It participates in seed and early stage capital requirements with an investment size of up to USD 25 million. The firm acts as a lead and co-lead investor and takes a seat on the board of directors. It also makes follow-on investments and does not invest in medical devices, diagnostic platforms and digital health. | Private Equity Investor | 01/01/2002 |
Berlin Institute of Health | Consultant / Advisor | 01/01/2021 |
LSP Management Group BV
 LSP Management Group BV Investment ManagersFinance EQT Life Sciences invests in companies located across the globe. The firm targets companies operating in the fields of therapeutics, medical devices, diagnostics and healthtech sectors. It provides financing for early and later stage capital requirements with an investment size of EUR 10 – 60 million. | Private Equity Investor | - |
Anciens postes connus de Karin Kleinhans
| Sociétés | Poste | Fin |
|---|---|---|
Cardior Pharmaceuticals GmbH
 Cardior Pharmaceuticals GmbH Pharmaceuticals: MajorHealth Technology Engages in discovery and development of therapies that target RNA as a means to prevent, repair & reverse diseases of the hearts | Directeur/Membre du Conseil | 31/12/2022 |
EQT Partners GmbH
 EQT Partners GmbH Investment ManagersFinance Acts as an alternative investment manager | Private Equity Investor | 31/12/2022 |
Arcum Therapeutics, Inc.
 Arcum Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical drug products | Directeur/Membre du Conseil | 31/12/2022 |
LSP Services Deutschland GmbH
 LSP Services Deutschland GmbH Investment ManagersFinance Acts as an alternative investment manager | Analyste en capital-investissement | 02/01/2022 |
T-Knife GmbH
 T-Knife GmbH BiotechnologyHealth Technology Operates as a biopharmaceutical company which develops novel therapeutics to fight cancer | Directeur/Membre du Conseil | 31/12/2021 |
Formation de Karin Kleinhans
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
41
Relations au 1er degré
9
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 9 |
|---|---|
LSP Management Group BV
LSP Management Group BV Investment ManagersFinance EQT Life Sciences invests in companies located across the globe. The firm targets companies operating in the fields of therapeutics, medical devices, diagnostics and healthtech sectors. It provides financing for early and later stage capital requirements with an investment size of EUR 10 – 60 million. | Finance |
EQT Partners GmbH
EQT Partners GmbH Investment ManagersFinance Acts as an alternative investment manager | Finance |
Universität Ulm
 Universität Ulm Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
LSP Services Deutschland GmbH
LSP Services Deutschland GmbH Investment ManagersFinance Acts as an alternative investment manager | Finance |
Merck Research Ventures
Merck Research Ventures Investment ManagersFinance Merck Research invests in companies located globally. The firm targets companies operating in the therapeutics sector. It participates in seed and early stage capital requirements with an investment size of up to USD 25 million. The firm acts as a lead and co-lead investor and takes a seat on the board of directors. It also makes follow-on investments and does not invest in medical devices, diagnostic platforms and digital health. | Finance |
Cardior Pharmaceuticals GmbH
Cardior Pharmaceuticals GmbH Pharmaceuticals: MajorHealth Technology Engages in discovery and development of therapies that target RNA as a means to prevent, repair & reverse diseases of the hearts | Health Technology |
Berlin Institute of Health | |
Arcum Therapeutics, Inc.
Arcum Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical drug products | Health Technology |
T-Knife GmbH
T-Knife GmbH BiotechnologyHealth Technology Operates as a biopharmaceutical company which develops novel therapeutics to fight cancer | Health Technology |
Choisissez Zonebourse 
